Dosulepin hydrochloride - Pain (Neuropathic)
You are here : Home > Formulary Search > Dosulepin hydrochloride - Pain (Neuropathic)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (Local)
Guidelines (National)
PAD Profile
ChemicalSubstance :
Dosulepin hydrochloride
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
Dothiepin, tricyclic antidepressants, tricyclics, TCAs
Brand Names Include :
Prothiaden
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Dosulepin hydrochloride is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Pain (Neuropathic).
Committee Recommendations (2)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
The PCN does not recommend the use of ‘off label’ dosulepin for the treatment of neuropathic pain.
See locally agreed neuropathic pain guidelines below
See locally agreed neuropathic pain guidelines below